Olympus announces the launch of ENDO-AID(1), an AI platform.
FREMONT, CA: Olympus Corporation announces the launch of ENDO-AID(1), a cutting-edge platform powered by artificial intelligence (AI) that includes the endoscopy application ENDO-AID CADe (computer-aided detection) for the colon. This new AI platform allows real-time display of automatically detected suspicious lesions and functions combined with Olympus' recently launched EVIS X1, its most advanced endoscopy system.
Being a global leader in designing and delivering innovative solutions for medical and surgical procedures, Olympus aims to improve patients' health and quality of life by offering advanced medical technologies. Its latest endoscopy system, EVIS X1, was created to set new image detection standards, characterization, staging, and treatment. With the newly launched endoscopy CAD platform ENDO-AID, Olympus is now improving the capabilities of EVIS X1 via AI technology, aiming to elevate the standard of endoscopy worldwide, whether for applications to disorders of the esophagus, colon, stomach, or other gastrointestinal organs.
ENDO-AID CADe: real-time computer-aided detection for endoscopy
ENDO-AID CADe is an application for the computer-aided detection powered by AI that runs on ENDO-AID. It uses a complicated algorithm through a neural network developed and trained by Olympus. With this new application's help, the system's sophisticated machine learning can alert the endoscopist in real-time when a suspected colonic lesion appears on the screen.
As a first step towards the future of endoscopic diagnosis and therapy
With ENDO-AID, the news feature of the EVIS X1 endoscopy system, Olympus has created the basis and infrastructure to install future applications backed by AI. "At Olympus we are committed to innovation and driving our research and development with passion," said Frank Drewalowski, Head of Endoscopic Solutions Division, Olympus Corporation. "Especially in AI, we recognize the power of elevating endoscopic imaging to uncharted levels. Considering ENDO-AID as a first step, we are planning additional AI-powered applications for image detection and characterization - not only for colonoscopy."
"With the launch of ENDO-AID, we are not only providing endoscopists across the world with an additional innovative tool," states Takaharu Yamada, Vice President, GI Endoscopy Business Leader, Endoscopic Solutions Division. "We are also preparing for the future and following our vision of putting CRC in the history books."